Ibon Martínez‐Arranz
Netherlands Metabolomics Centre(NL)Zubiola (Spain)(ES)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Diet, Metabolism, and Disease, Metabolomics and Mass Spectrometry Studies, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Diseases and Immunity
Most-Cited Works
- → Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis(2017)266 cited
- → Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression(2012)225 cited
- → Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis(2018)186 cited
- → Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts(2018)156 cited
- → Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis(2013)122 cited
- → Role of aramchol in steatohepatitis and fibrosis in mice(2017)114 cited
- → Enhancing metabolomics research through data mining(2015)111 cited
- → Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122(2020)85 cited
- → Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer(2019)84 cited
- → Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)(2023)67 cited